Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Spectral Medical Inc T.EDT

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  EDTXF

Spectral Medical Inc is a Phase III company developing the first theranostic treatment for patients with septic shock.
Price: $1.08 | Change: +$0.04 | %Change: +3.85%
Volume: 196,063 | Day High/Low: 1.09/1.05 | 52 Week High/Low: 1.18/0.26
View modes: 
0 stars

RE:Fda

++ Pfizer or other large bios will be watching spectral per ZACKS report $3+ billion opportunity and these numbers are for US and have not included worldwide projections. IMO as posted before Toray...read more
0 stars

RE:Fda

That assumption is wrong....have seen companies approved and used in Europe failing to get FDA approval. I don't mean to say Spectral won't get the approval but the assumption is wrong. jmho  rate and reply
0 stars

annual and special meeting

may 12th toronto  rate and reply
1 star

Fda

If it works in Japan and Europe it will work here.  Seems to me the data is already in from the 100K people who have been tested. Physer or some other large drug company will buy EDT book if  rate and reply
1 star

RE:RE:RE:Volatility etc..

Correct....I would say they are conservative and all the analysts are playing safe and waiting for the FDA approval before recommending a 'BUY" as it is absolutely a long term stock if it gets...read more
1 star

RE:RE:RE:Volatility etc..

"None of the current reports take into account ..." Isn't it time for us as shareholders to ask ourselves (or someone) why that is...? MM  rate and reply
1 star

RE:RE:Volatility etc..

None of the "current" reports take into account that the new exclusions set back last April has significantly improved the success rate of the treatment by focusing and targeting those who will...read more
1 star

This was really "odd"

So ....typically in after hours trading the stock gets cut down from the closing price at the bell, anywhere from 1 cent to as much as 4 cents.  ( Which ... imo ... should never be allowed and I'm not...read more
1 star

RE:RE:RE:Volatility etc..

Very good news that the rate of increase in patients has picked up again ! One wonders, however, how relevant those numbers will be in the event of : favourable stopping rules under PMA, and or...read more
1 star

RE:RE:Volatility etc..

Right..  New Presentation .. http://spectraldx.com/assets/spectral-medical-ir-apr2015.pdf 346 patients randomized as of April 22, 2015 (76 since April, 2014 additional exclusion criterion)  rate and reply
2.5 stars

Interesting spike

Here's a company who's stock spiked 16 % this morning on news that they were pursuing EAP through the new FDA program announced last week. Cytosorbents sees it as a key element of their go forward...read more
1 star

RE:RE:Volatility etc..

This is my last comment on this.. You better check FDA site about what is involved with PMA (rules for faster review and approval of Medical Devices) while the clinical Trial is in progress..  This...read more
1 star

RE:RE:Volatility etc..

something I came across this morning, while I await the someyoungguy poster to finish his coffee and share his findings....... .http://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life...read more
1 star

RE:Volatility etc..

According to the April 22nd IR presentation, the patient enrollment count was 76 patients.  On March 26th, the Zack's guy stated that the enrollment number was 66 patients.  So that's 10 more patients...read more
1 star

RE:Volatility is nice...UNCERTAINTY is better

Oh Goodie.............Hurry back!!!!!!!!  rate and reply
2 stars

Volatility is nice...UNCERTAINTY is better

UNCERTAINTY has been the preferred method of description when attampts to promote Spectral have been made..."agreed"...VOLATILITY is nice and rather obvious given the ability of Spectral to be moved...read more
1 star

RE:Volatility etc..

5 hours ago :  Quote : "4.. Some milestones are given.. Others are meaningful..  If FDA agrees to interim analysis, I think that would be meaningful.. If we hear about patient enrollment, that...read more
1 star

RE:RE:Volatility etc..

Yes.. I have.. I track every thing that goes on with EDT in a lot more detail then most here..  FDA) has accepted the Company's plan, and related content, for a rolling Pre Market Approval (PMA...read more
1 star

RE:Volatility etc..

See..... that's what I'm talking about, you just stated IF the FDA agrees to intermediate analysis. Have you read the last news announcement from TWO days ago ?  rate and reply
2.5 stars

Volatility etc..

Going forward, until the interim analysis and as that gets nearer, expect a lot of volatility..  Whether it is: 1. Anaylyst review of target price or just putting an arbitrary potential price.. 2...read more